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Abstract
Background: Conventional single-incision laparoscopic surgery has been successfully employed for treatment of
ovarian endometriomas. However, this technique presents surgeons with formidable ergonomic challenges, that make
its widespread adoption unlikely. Robotic assistance in single-incision laparoscopic surgery provides adequate instrument
triangulation through a single fulcrum, while eliminating ergonomic challenges to the surgeon. The objective of this
video is to describe a novel technique of laparoscopic excision and ablation of ovarian endometriomas with single-site
robotic assistance. Footage from a single surgical case is shown in our video. The da Vinci Si surgical system with da Vinci
Single-Site platform was utilized. A flexible CO2 laser fiber was employed as the main energy tool.
To describe a technique of single-incision laparoscopic excision and ablation of endometriomas with robotic assistance.
Footage from a single surgical case is shown in this video. The da Vinci Si surgical system with da Vinci Single-Site
platform was utilized. A flexible CO2 laser fiber was employed as the main energy tool.
Results: Our technique achieved excellent surgical, clinical and cosmetic results, with complete excision and ablation of
the endometriomas and no complications. The procedure was completed in day-surgery setting.
Conclusion: Our step-by-step video tutorial shows how the dedicated single incision laparoscopy technology for the
da Vinci Si surgical system can be safely and effectively applied to the excision and ablation of ovarian endometriomas.
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Background
Endometriomas are peculiar ovarian pseudocysts that lack a
true capsule and originate from the invagination and disten-
sion of an area of the ovarian cortex. Endometriomas can
negatively impact ovarian reserve, cause pain, and can also
raise the suspicion of ovarian malignancy. However conser-
vative surgical intervention may be indicated in women of
reproductive age. Surgical removal of endometriomas has
been associated with significant loss of ovarian follicular
reserve and even premature ovarian failure [1]. Therefore,
safe and reproducible techniques of endometrioma excision
are of paramount clinical importance [2]. Conventional
single-incision laparoscopic surgery has been successfully
employed for treatment of ovarian endometriomas [3].
Single-incision laparoscopic surgery offers the potential for
improved surgical cosmesis, decreased postoperative pain
and decreased risk of perioperative complications. However,
because it requires a single fulcrum for all of the surgical
instruments employed, this technique represents the
epitome of ergonomic challenge for surgeons [4]. The daVinci
Single-Site (dVSS) platform was approved by the FDA in 2013
to perform hysterectomy and salpingo-oohporectomy with
the da Vinci Si Surgical System (Intuitive Surgical, Inc,
Sunnyvale, CA) through a single umbilical entry. The dVSS
consists of a 2.5 cm silicon single port device with five
separate lumens (for insufflation, robotic camera, two robotic
instrument arms and an assistant instrument).
The objective of this video article is to describe a
safe and reproducible technique of minimally invasive
excision and ablation of ovarian endometriomas
employing the dVSS platform. Video of procedure.
The video is available to download if requested to
frpjournal@biomedcentral.com.
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Methods
Twenty-six year old nulligravida with recent diagnosis of
large symptomatic bilateral complex ovarian masses,
highly suggestive for endometriomas. The patient’s BMI
was 23 kg/m2 and had a negative surgical history. The
da Vinci Single-Site platform was utilized with 250 mm
curved instruments cannulas and the following semi-
rigid 5 mm instruments: Maryland Dissector, Monopolar
Cautery Hook, Fundus Grasper, Crocodile Grasper and
Suction Irrigator. The Maryland Dissector was used to
guide a flexible CO2 laser fiber (IntelliGuide Laser System,
BeamPath flexible fiber and FlexGuide Robotic, Omni
Guide, Inc. Cambridge, MA) that was introduced through
an 8 mm cannula in the assistant instrument lumen of the
single-port device. Our video demonstrates a complete
endometrioma stripping in the right ovary and a partial
stripping in the left ovary, with CO2 laser ablation of the
remnant portion of endometrioma overlying the ovarian
hilum. Such technique, described by Donnez et al. in con-
ventional multi-port laparoscopy, has been demonstrated
to have a minimal impact on ovarian reserve [5].
Complete hemostasis was maintained without the use
of electrosurgery on the endometrioma bed. Regener-
ated oxidized cellulose (Gynecare Interceed, Ethicon
US LLC, Cincinnati, OH) was placed around the ad-
nexa at the end of the operation to reduce the chance
of postoperative adhesions.
Results and discussion
Our video illustrates in detail a technique for excision
and ablation of large bilateral endometriomas employing
single-site technology for with the da Vinci Si surgical
system. In particular, we demonstrate the single-site
feasibility of a previously described technique of partial
stripping and CO2 laser ablation. The operation was car-
ried out with minimal mechanical limitations with 5 mm
nonwristed semi-rigid instruments. Curved instrument
cannulas provide ideal instrument triangulation, and the
real-time inversion of laterality provided by the comput-
erized surgical platform makes the surgeon’s movements
at the console intuitive and purposeful. This patient
underwent an uncomplicated procedure lasting 127 min
and was discharged home on the day of surgery. Postop-
erative course was unremarkable and cosmetic results
were excellent.
Novel single incision laparoscopy technology for the da
Vinci Si surgical system can be safely applied to the exci-
sion and ablation of ovarian endometriomas. Optimal tri-
angulation and inversion of laterality are provided by the
system itself, thus the dVSS removes the typical adoption
barriers of single-incision laparoscopy [6] and is immedi-
ately accessible to surgeons who are proficient in
computer-assisted surgery. Use of this technology can be
considered in select patients desiring an ultra-minimally
invasive approach to ovarian endometriosis, such as young
women in reproductive surgery and infertility practices.
Of note, because this does not yet constitute an FDA-
approved indication for the use of the dVSS (such as hys-
terectomy and salpingo-oophorectomy), all patients
should be specifically informed that this technology will
be used, and written consent should be obtained.
Conclusions
The da Vinci Single-Site platform, currently FDA-approved
for hysterectomy and salpingo-oophorectomy, is an enab-
ling tool for minimally invasive conservative ovarian sur-
gery for advanced endometriosis.
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